When antidepressants called selective serotonin reuptake inhibitors, or SSRIs, burst onto the scene in the 1980s, they provided much-needed relief for millions suffering from mood disorders like depression. However, even as SSRIs have become one of the most commonly prescribed drugs in the world, the details of how they interact with the brain remain somewhat mysterious.

Recently a research team at The Rockefeller University made strides in unraveling the brain circuitry in mice that responds to SSRIs, and pinpointed the cells where the response starts, information that could be used to develop more-effective treatments. Their work was published in Neuron.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy